These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Locoregional management of hepatic metastasis from primary uveal melanoma. Sato T Semin Oncol; 2010 Apr; 37(2):127-38. PubMed ID: 20494705 [TBL] [Abstract][Full Text] [Related]
25. Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo. Notting I; Buijs J; Mintardjo R; van der Horst G; Vukicevic S; Lowik C; Schalij-Delfos N; Keunen J; van der Pluijm G Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4882-9. PubMed ID: 17962434 [TBL] [Abstract][Full Text] [Related]
30. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells. Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L Acta Ophthalmol; 2008 Nov; 86 Thesis 4():26-34. PubMed ID: 19032679 [TBL] [Abstract][Full Text] [Related]
31. Differential expression of Mart-1 in human uveal melanoma cells. Wang J; Jia R; Yao Y; Cun B; Huang X; Gu P; Ge S; Fan X Mol Med Rep; 2011; 4(5):799-803. PubMed ID: 21667026 [TBL] [Abstract][Full Text] [Related]
32. Epidemiology and management of uveal melanoma. Yonekawa Y; Kim IK Hematol Oncol Clin North Am; 2012 Dec; 26(6):1169-84. PubMed ID: 23116575 [TBL] [Abstract][Full Text] [Related]
33. Intravascular presence of tumor cells as prognostic parameter in uveal melanoma: a 35-year survey. Ly LV; Odish OF; Wolff-Rouendaal Dd; Missotten GS; Luyten GP; Jager MJ Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):658-65. PubMed ID: 19797220 [TBL] [Abstract][Full Text] [Related]
34. Expression of bcl-2 in uveal malignant melanoma. Jay V; Yi Q; Hunter WS; Zielenska M Arch Pathol Lab Med; 1996 May; 120(5):497-8. PubMed ID: 8639055 [TBL] [Abstract][Full Text] [Related]
35. NBS1 expression as a prognostic marker in uveal melanoma. Ehlers JP; Harbour JW Clin Cancer Res; 2005 Mar; 11(5):1849-53. PubMed ID: 15756009 [TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target. All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005 [TBL] [Abstract][Full Text] [Related]
38. [What else can we do for uveal melanoma]. Li B; Xu XL Zhonghua Yan Ke Za Zhi; 2009 Apr; 45(4):289-92. PubMed ID: 19575957 [TBL] [Abstract][Full Text] [Related]
39. Role of epidermal growth factor receptor in the metastasis of intraocular melanomas. Ma D; Niederkorn JY Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1067-75. PubMed ID: 9620065 [TBL] [Abstract][Full Text] [Related]
40. Diagnosis and treatment of uveal melanoma. Shields JA; Shields CL; De Potter P; Singh AD Semin Oncol; 1996 Dec; 23(6):763-7. PubMed ID: 8970600 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]